Μετάβαση στο περιεχόμενο

ΕτικέταAblynx

ReViral Closes $55 Million Series B to Advance RSV Treatment

London-based ReViral announced the completion of a Series B financing worth $55 million. The financing was jointly led by New Leaf Venture Partners and Novo Ventures, part of Novo Holdings, with new investors Perceptive Advisors. Existing investors also participated, including Andera Partners, … Continue Reading ReViral Closes $55 Million Series B to Advance RSV Treatment

Top 10 M&A Deals of January—June 2018 Value of Mergers and Acquisitions, Volume of Transactions, on Pace to Surpass 2017

    EY’s projection that the volume of mergers and acquisitions (M&A) in “life sciences”—which includes biopharma and medical technology segments—will go well past last year’s $200 billion annual volume of … Continue Reading Top 10 M&A Deals of January—June 2018 Value of Mergers and Acquisitions, Volume of Transactions, on Pace to Surpass 2017